Cargando…
Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
Antithymocyte globulin (ATG) is used in the prevention of graft-versus-host disease during allogeneic hematopoietic stem cell transplantation. It is generally accepted that ATG mediates its immunosuppressive effect primarily via depletion of T cells. Here, we analyzed the impact of ATG-Fresenius (no...
Autores principales: | Roider, Tobias, Katzfuß, Michael, Matos, Carina, Singer, Katrin, Renner, Kathrin, Oefner, Peter J., Dettmer-Wilde, Katja, Herr, Wolfgang, Holler, Ernst, Kreutz, Marina, Peter, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187881/ https://www.ncbi.nlm.nih.gov/pubmed/27973435 http://dx.doi.org/10.3390/ijms17122081 |
Ejemplares similares
-
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
por: Ugele, Ines, et al.
Publicado: (2019) -
Anti-Thymocyte Globulin Treatment Augments 1,25-Dihydroxyvitamin D3 Serum Levels in Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Matos, Carina, et al.
Publicado: (2022) -
Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
por: Singer, Katrin, et al.
Publicado: (2019) -
1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation
por: Peter, Katrin, et al.
Publicado: (2020) -
Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)